[Hypertrophic cardiomyopathies and ATTR amyloidosis - a current review for clinical practice]. / Hypertrophe Kardiomyopathien und die kardiale ATTR-Amyloidose ­ eine aktuelle Übersicht für den klinischen Alltag.

Cardiomyopathies include dilated and restrictive cardiomyopathies as well as the various forms of hypertrophic cardiomyopathies (HCM). By definition, HCM is considered to occur when left ventricular wall thickness is ≥ 15 mm. This may be masked by genetic sarcomeric diseases, storage diseases, or syndromes. In clinical practice, sarcomere mutations and the cardiac amyloidoses are of particular interest because they are not always easy to distinguish from each other and early diagnosis of the disease is important for prognosis.